Scopus by Title (Ref)
Articles that cite the referenced work, matched by title from the Scopus database.
Synthesis, Characterization, and Comparative Biological Evaluation of Hydroxylated Isoniazid Schiff Base Derivatives: An In-Vitro, In-Vivo and In-Silico Study
Journal of Molecular Structure
5 February 2027
Rahman M.O.
Capillary-Associated Microglia in Neurovascular Coupling: Localization, Mechanisms, and Disease Implications
Journal of Neuroinflammation
December 2026
Lu H.
Open Access
Bioreactor-based production of eumelanin nanoparticles by Streptomyces glaucescens NEAE-H: physicochemical characterization, anticancer and anti-inflammatory activities, and in silico analysis
Scientific Reports
December 2026
El-Naggar N.E.A.
Open Access
A New Survey about Dual-Acting PARP/COX-2 Inhibitors as Cancer Chemopreventive Agents
Iranian Journal of Pharmaceutical Research
December 2026
Rabbani M.I.M.
Open Access
Small RNA sequencing identifies T cell-derived tsRNAs as novel biomarkers for diagnosis and clinical assessment of rheumatoid arthritis
International Immunopharmacology
1 November 2026
Tao S.S.
Design, synthesis, structure–activity relationship and in-silico studies of novel pyrazolo[1,5-a]pyrimidine derivatives as selective COX-2 inhibitors with promising anti-inflammatory activity and safety profile
Bioorganic Chemistry
15 October 2026
Helmy A.O.M.
Open Access
Synthesis, structural characterization and biological evaluation of a novel pyrimidinetrione–chalcone sulphonamide as a COX-2-targeted scaffold
Bioorganic Chemistry
5 September 2026
Dewangan S.
Cyclooxygenase-2 Expression in Oral Squamous Cell Carcinoma and Dysplasia of Oral Epithelium – A Comparative Study
Journal of Health Science and Medical Research
September-October 2026
Ekambaram D.
Open Access
Prinsepia utilis Royle (Himalayan wild cherry) as a source of bioactive compounds and functional oil: Nutraceutical and pharmacological perspectives
Pharmanutrition
September 2026
Suvedi D.
Comparative in silico evaluation of selective and preferential COX-2 inhibitors: Insights from molecular docking, molecular dynamics, ADMET, and toxicity profiling
Computational Biology and Chemistry
August 2026
Amin A.A.
In silico prediction of ADME/tox and molecular docking of secondary metabolites from agro-industrial waste of Carapa guianensis Aubl
Journal of the Indian Chemical Society
July 2026
Santos K.I.P.d.
Open Access
Cyclooxygenase Modulatory Activity of γ-Oryzanol from Pathumthani 1 Rice Bran: Integration of HPLC Composition, Cell Assays, and Molecular Docking
Trends in Sciences
July 2026
Anukanon S.
Open Access
Valsartan promotes neuroprotection in Parkinson's disease via epigenetic modulation and activation of the ASCL1/Nurr1 pathway
Life Sciences
1 June 2026
Gowied H.G.
Comparative evaluation of efficacy of ethyl acetate and hexane extracts of Drynaria quercifolia on FCA-induced arthritic Wistar albino rats: Phytochemical profiling via GC-MS and in silico pharmacokinetics evaluation
Pharmacological Research Natural Products
June 2026
Modak D.
In Silico Design and SAR Studies Evaluation of New Amide Compounds as COX-1 and 2 Inhibitors
Iraqi Journal of Pharmacy
June 2026
Khaleel R.A.S.
Open Access
Repurposing of Potential Curcumin Derivatives Against Cyclooxygenase-2 Using In Silico Methods and Its Implications in Neurological Disorders
Biotechnology and Applied Biochemistry
June 2026
Padture A.
Open Access
Novel thiadiazole derivatives: synthesis, in silico, in vitro and in vivo evaluation of analgesic and anti-inflammatory activities
Bioorganic Chemistry
May 2026
Eken H.
An Explainable 2D-QSAR Machine Learning Approach for Predicting COX-2 Inhibitory Activity Using Molecular Fingerprints
Pharmaceuticals
May 2026
Ouassaf M.
Open Access
Design, Synthesis, and Evaluation of New Polyhydroxylated Bis-Chalcones as Potential COX-2 Selective Inhibitors
Chemmedchem
28 April 2026
Pereira R.
Open Access
Piperazine-Thiourea Hybrids as Novel Antiplatelet Agents Targeting COX-1: Synthesis, in Vitro, and in Silico Evaluation
ACS Omega
14 April 2026
Pereira G.R.C.
Open Access
Molecular and Pharmacokinetic Rationale for the Use of Chelidonium majus L. in Wound Healing: An In Silico and In Vitro Validation
Molecules
April 2026
Borges A.
Open Access
Design, Synthesis, and In Vitro Enzymatic Evaluation of Novel Flavone Derivatives as Dual COX-2/5-LOX Inhibitors Supported by Molecular Docking and ADMET Analysis
Current Issues in Molecular Biology
March 2026
Fraj E.
Open Access
Design and development of pyrazole–thiazole hybrid derivatives as anti-inflammatory and anti-oxidant agents
Journal of Molecular Structure
25 February 2026
Patil S.M.
Open Access